TCL Archive ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard September 13, 2002
TCL Archive GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds April 21, 1989